-
1
-
-
79952232216
-
Global cancer statistics
-
Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin. 2011, 61:69-90.
-
(2011)
CA Cancer J. Clin.
, vol.61
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
77957734999
-
Epidemiology and management of hepatocellular carcinoma
-
viii.
-
J.D. Yang, L.R. Roberts, Epidemiology and management of hepatocellular carcinoma, Infect Dis. Clin. North Am. 24 (2010) 899-919, viii.
-
(2010)
Infect Dis. Clin. North Am.
, vol.24
, pp. 899-919
-
-
Yang, J.D.1
Roberts, L.R.2
-
3
-
-
77954531753
-
Epidemiology of hepatocellular carcinoma
-
Sherman M. Epidemiology of hepatocellular carcinoma. Oncology 2010, 78(Suppl. 1):7-10.
-
(2010)
Oncology
, vol.78
, Issue.SUPPL. 1
, pp. 7-10
-
-
Sherman, M.1
-
4
-
-
34848881905
-
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
-
Calvisi D.F., Ladu S., Gorden A., Farina M., Lee J.S., Conner E.A., Schroeder I., Factor V.M., Thorgeirsson S.S. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J. Clin. Invest. 2007, 117:2713-2722.
-
(2007)
J. Clin. Invest.
, vol.117
, pp. 2713-2722
-
-
Calvisi, D.F.1
Ladu, S.2
Gorden, A.3
Farina, M.4
Lee, J.S.5
Conner, E.A.6
Schroeder, I.7
Factor, V.M.8
Thorgeirsson, S.S.9
-
5
-
-
0036384160
-
Molecular pathogenesis of human hepatocellular carcinoma
-
Kern M.A., Breuhahn K., Schirmacher P. Molecular pathogenesis of human hepatocellular carcinoma. Adv. Cancer Res. 2002, 86:67-112.
-
(2002)
Adv. Cancer Res.
, vol.86
, pp. 67-112
-
-
Kern, M.A.1
Breuhahn, K.2
Schirmacher, P.3
-
6
-
-
0030663283
-
Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution
-
Hsu H.C., Cheng W., Lai P.L. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Cancer Res. 1997, 57:5179-5184.
-
(1997)
Cancer Res.
, vol.57
, pp. 5179-5184
-
-
Hsu, H.C.1
Cheng, W.2
Lai, P.L.3
-
7
-
-
0038786861
-
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma
-
Capurro M., Wanless I.R., Sherman M., Deboer G., Shi W., Miyoshi E., Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 2003, 125:89-97.
-
(2003)
Gastroenterology
, vol.125
, pp. 89-97
-
-
Capurro, M.1
Wanless, I.R.2
Sherman, M.3
Deboer, G.4
Shi, W.5
Miyoshi, E.6
Filmus, J.7
-
8
-
-
79251599238
-
Glypican-3: a new target for cancer immunotherapy
-
Ho M., Kim H. Glypican-3: a new target for cancer immunotherapy. Eur. J. Cancer 2011, 47:333-338.
-
(2011)
Eur. J. Cancer
, vol.47
, pp. 333-338
-
-
Ho, M.1
Kim, H.2
-
9
-
-
68649097790
-
Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more
-
Kandil D.H., Cooper K. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more. Adv. Anat. Pathol. 2009, 16:125-129.
-
(2009)
Adv. Anat. Pathol.
, vol.16
, pp. 125-129
-
-
Kandil, D.H.1
Cooper, K.2
-
10
-
-
57149085273
-
Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer
-
Ishiguro T., Sugimoto M., Kinoshita Y., Miyazaki Y., Nakano K., Tsunoda H., Sugo I., Ohizumi I., Aburatani H., Hamakubo T., Kodama T., Tsuchiya M., Yamada-Okabe H. Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. Cancer Res. 2008, 68:9832-9838.
-
(2008)
Cancer Res.
, vol.68
, pp. 9832-9838
-
-
Ishiguro, T.1
Sugimoto, M.2
Kinoshita, Y.3
Miyazaki, Y.4
Nakano, K.5
Tsunoda, H.6
Sugo, I.7
Ohizumi, I.8
Aburatani, H.9
Hamakubo, T.10
Kodama, T.11
Tsuchiya, M.12
Yamada-Okabe, H.13
-
11
-
-
33750983031
-
Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas
-
Wang X.Y., Degos F., Dubois S., Tessiore S., Allegretta M., Guttmann R.D., Jothy S., Belghiti J., Bedossa P., Paradis V. Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum. Pathol. 2006, 37:1435-1441.
-
(2006)
Hum. Pathol.
, vol.37
, pp. 1435-1441
-
-
Wang, X.Y.1
Degos, F.2
Dubois, S.3
Tessiore, S.4
Allegretta, M.5
Guttmann, R.D.6
Jothy, S.7
Belghiti, J.8
Bedossa, P.9
Paradis, V.10
-
12
-
-
68849113736
-
Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies
-
Nassar A., Cohen C., Siddiqui M.T. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies. Diagn. Cytopathol. 2009, 37:629-635.
-
(2009)
Diagn. Cytopathol.
, vol.37
, pp. 629-635
-
-
Nassar, A.1
Cohen, C.2
Siddiqui, M.T.3
-
13
-
-
42549105933
-
Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study
-
Ligato S., Mandich D., Cartun R.W. Utility of glypican-3 in differentiating hepatocellular carcinoma from other primary and metastatic lesions in FNA of the liver: an immunocytochemical study. Mod. Pathol. 2008, 21:626-631.
-
(2008)
Mod. Pathol.
, vol.21
, pp. 626-631
-
-
Ligato, S.1
Mandich, D.2
Cartun, R.W.3
-
14
-
-
22244464888
-
Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma
-
Filmus J., Capurro M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol. Diagn. 2004, 8:207-212.
-
(2004)
Mol. Diagn.
, vol.8
, pp. 207-212
-
-
Filmus, J.1
Capurro, M.2
-
15
-
-
77954310523
-
Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma
-
Zhang Q., Xiao Q., Lin Z., Ying X., Li Z., Lin J.M. Development of a competitive radioimmunoassay for glypican-3 and the clinical application in diagnosis of hepatocellular carcinoma. Clin. Biochem. 2010, 43:1003-1008.
-
(2010)
Clin. Biochem.
, vol.43
, pp. 1003-1008
-
-
Zhang, Q.1
Xiao, Q.2
Lin, Z.3
Ying, X.4
Li, Z.5
Lin, J.M.6
-
16
-
-
51849088640
-
The role of glypican-3 in the regulation of body size and cancer
-
Filmus J., Capurro M. The role of glypican-3 in the regulation of body size and cancer. Cell Cycle 2008, 7:2787-2790.
-
(2008)
Cell Cycle
, vol.7
, pp. 2787-2790
-
-
Filmus, J.1
Capurro, M.2
-
17
-
-
59449101443
-
Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation, Breast Cancer Res
-
Treat
-
I. Stigliano, L. Puricelli, J. Filmus, M.C. Sogayar, E. Bal de Kier Joffe, M.G. Peters, Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation, Breast Cancer Res. Treat 114 (2009) 251-262.
-
(2009)
, vol.114
, pp. 251-262
-
-
Stigliano, I.1
Puricelli, L.2
Filmus, J.3
Sogayar, M.C.4
Bal de Kier Joffe, E.5
Peters, M.G.6
-
18
-
-
80051532479
-
Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-beta2
-
Sun C.K., Chua M.S., He J., So S.K. Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-beta2. Neoplasia 2011, 13:735-747.
-
(2011)
Neoplasia
, vol.13
, pp. 735-747
-
-
Sun, C.K.1
Chua, M.S.2
He, J.3
So, S.K.4
-
19
-
-
0037428667
-
Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling
-
Midorikawa Y., Ishikawa S., Iwanari H., Imamura T., Sakamoto H., Miyazono K., Kodama T., Makuuchi M., Aburatani H. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer 2003, 103:455-465.
-
(2003)
Int. J. Cancer
, vol.103
, pp. 455-465
-
-
Midorikawa, Y.1
Ishikawa, S.2
Iwanari, H.3
Imamura, T.4
Sakamoto, H.5
Miyazono, K.6
Kodama, T.7
Makuuchi, M.8
Aburatani, H.9
-
21
-
-
78049502871
-
The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation
-
Lai J.P., Oseini A.M., Moser C.D., Yu C., Elsawa S.F., Hu C., Nakamura I., Han T., Aderca I., Isomoto H., Garrity-Park M.M., Shire A.M., Li J., Sanderson S.O., Adjei A.A., Fernandez-Zapico M.E., Roberts L.R. The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation. Hepatology 2010, 52:1680-1689.
-
(2010)
Hepatology
, vol.52
, pp. 1680-1689
-
-
Lai, J.P.1
Oseini, A.M.2
Moser, C.D.3
Yu, C.4
Elsawa, S.F.5
Hu, C.6
Nakamura, I.7
Han, T.8
Aderca, I.9
Isomoto, H.10
Garrity-Park, M.M.11
Shire, A.M.12
Li, J.13
Sanderson, S.O.14
Adjei, A.A.15
Fernandez-Zapico, M.E.16
Roberts, L.R.17
-
22
-
-
49349103711
-
Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway
-
Cheng W., Tseng C.J., Lin T.T., Cheng I., Pan H.W., Hsu H.C., Lee Y.M. Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway. Carcinogenesis 2008, 29:1319-1326.
-
(2008)
Carcinogenesis
, vol.29
, pp. 1319-1326
-
-
Cheng, W.1
Tseng, C.J.2
Lin, T.T.3
Cheng, I.4
Pan, H.W.5
Hsu, H.C.6
Lee, Y.M.7
-
23
-
-
23944506289
-
RNA interference is an antiviral defence mechanism in Caenorhabditis elegans
-
Wilkins C., Dishongh R., Moore S.C., Whitt M.A., Chow M., Machaca K. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 2005, 436:1044-1047.
-
(2005)
Nature
, vol.436
, pp. 1044-1047
-
-
Wilkins, C.1
Dishongh, R.2
Moore, S.C.3
Whitt, M.A.4
Chow, M.5
Machaca, K.6
-
24
-
-
84862829936
-
-
CRC Press, Enfield, N.H.
-
Gaur R.K. RNAi Technology 2011, CRC Press, Enfield, N.H. 1st ed.
-
(2011)
RNAi Technology
-
-
Gaur, R.K.1
-
25
-
-
1542336952
-
Rational siRNA design for RNA interference
-
Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 2004, 22:326-330.
-
(2004)
Nat. Biotechnol.
, vol.22
, pp. 326-330
-
-
Reynolds, A.1
Leake, D.2
Boese, Q.3
Scaringe, S.4
Marshall, W.S.5
Khvorova, A.6
-
26
-
-
57049157619
-
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells
-
Nakano K., Orita T., Nezu J., Yoshino T., Ohizumi I., Sugimoto M., Furugaki K., Kinoshita Y., Ishiguro T., Hamakubo T., Kodama T., Aburatani H., Yamada-Okabe H., Tsuchiya M. Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2009, 378:279-284.
-
(2009)
Biochem. Biophys. Res. Commun.
, vol.378
, pp. 279-284
-
-
Nakano, K.1
Orita, T.2
Nezu, J.3
Yoshino, T.4
Ohizumi, I.5
Sugimoto, M.6
Furugaki, K.7
Kinoshita, Y.8
Ishiguro, T.9
Hamakubo, T.10
Kodama, T.11
Aburatani, H.12
Yamada-Okabe, H.13
Tsuchiya, M.14
-
27
-
-
0038054270
-
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
-
Nakatsura T., Yoshitake Y., Senju S., Monji M., Komori H., Motomura Y., Hosaka S., Beppu T., Ishiko T., Kamohara H., Ashihara H., Katagiri T., Furukawa Y., Fujiyama S., Ogawa M., Nakamura Y., Nishimura Y. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem. Biophys. Res. Commun. 2003, 306:16-25.
-
(2003)
Biochem. Biophys. Res. Commun.
, vol.306
, pp. 16-25
-
-
Nakatsura, T.1
Yoshitake, Y.2
Senju, S.3
Monji, M.4
Komori, H.5
Motomura, Y.6
Hosaka, S.7
Beppu, T.8
Ishiko, T.9
Kamohara, H.10
Ashihara, H.11
Katagiri, T.12
Furukawa, Y.13
Fujiyama, S.14
Ogawa, M.15
Nakamura, Y.16
Nishimura, Y.17
-
28
-
-
33947396135
-
Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis
-
Di Tommaso L., Franchi G., Park Y.N., Fiamengo B., Destro A., Morenghi E., Montorsi M., Torzilli G., Tommasini M., Terracciano L., Tornillo L., Vecchione R., Roncalli M. Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis. Hepatology 2007, 45:725-734.
-
(2007)
Hepatology
, vol.45
, pp. 725-734
-
-
Di Tommaso, L.1
Franchi, G.2
Park, Y.N.3
Fiamengo, B.4
Destro, A.5
Morenghi, E.6
Montorsi, M.7
Torzilli, G.8
Tommasini, M.9
Terracciano, L.10
Tornillo, L.11
Vecchione, R.12
Roncalli, M.13
-
29
-
-
33750430854
-
Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules
-
Libbrecht L., Severi T., Cassiman D., Vander Borght S., Pirenne J., Nevens F., Verslype C., van Pelt J., Roskams T. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am. J. Surg. Pathol. 2006, 30:1405-1411.
-
(2006)
Am. J. Surg. Pathol.
, vol.30
, pp. 1405-1411
-
-
Libbrecht, L.1
Severi, T.2
Cassiman, D.3
Vander Borght, S.4
Pirenne, J.5
Nevens, F.6
Verslype, C.7
van Pelt, J.8
Roskams, T.9
-
30
-
-
38449095281
-
Glypican-3 immunocytochemistry in liver fine-needle aspirates: a novel stain to assist in the differentiation of benign and malignant liver lesions
-
Kandil D., Leiman G., Allegretta M., Trotman W., Pantanowitz L., Goulart R., Evans M. Glypican-3 immunocytochemistry in liver fine-needle aspirates: a novel stain to assist in the differentiation of benign and malignant liver lesions. Cancer 2007, 111:316-322.
-
(2007)
Cancer
, vol.111
, pp. 316-322
-
-
Kandil, D.1
Leiman, G.2
Allegretta, M.3
Trotman, W.4
Pantanowitz, L.5
Goulart, R.6
Evans, M.7
-
31
-
-
22244480967
-
Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling
-
Capurro M.I., Xiang Y.Y., Lobe C., Filmus J. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling. Cancer Res. 2005, 65:6245-6254.
-
(2005)
Cancer Res.
, vol.65
, pp. 6245-6254
-
-
Capurro, M.I.1
Xiang, Y.Y.2
Lobe, C.3
Filmus, J.4
-
32
-
-
57149085273
-
Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer
-
Ishiguro T., Sugimoto M., Kinoshita Y., Miyazaki Y., Nakano K., Tsunoda H., Sugo I., Ohizumi I., Aburatani H., Hamakubo T., Kodama T., Tsuchiya M., Yamada-Okabe H. Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. Cancer Res. 2008, 68:9832-9838.
-
(2008)
Cancer Res.
, vol.68
, pp. 9832-9838
-
-
Ishiguro, T.1
Sugimoto, M.2
Kinoshita, Y.3
Miyazaki, Y.4
Nakano, K.5
Tsunoda, H.6
Sugo, I.7
Ohizumi, I.8
Aburatani, H.9
Hamakubo, T.10
Kodama, T.11
Tsuchiya, M.12
Yamada-Okabe, H.13
-
33
-
-
33646721733
-
Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma
-
Komori H., Nakatsura T., Senju S., Yoshitake Y., Motomura Y., Ikuta Y., Fukuma D., Yokomine K., Harao M., Beppu T., Matsui M., Torigoe T., Sato N., Baba H., Nishimura Y. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Clin. Cancer Res. 2006, 12:2689-2697.
-
(2006)
Clin. Cancer Res.
, vol.12
, pp. 2689-2697
-
-
Komori, H.1
Nakatsura, T.2
Senju, S.3
Yoshitake, Y.4
Motomura, Y.5
Ikuta, Y.6
Fukuma, D.7
Yokomine, K.8
Harao, M.9
Beppu, T.10
Matsui, M.11
Torigoe, T.12
Sato, N.13
Baba, H.14
Nishimura, Y.15
-
34
-
-
0034614637
-
The hallmarks of cancer
-
Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
-
(2000)
Cell
, vol.100
, pp. 57-70
-
-
Hanahan, D.1
Weinberg, R.A.2
-
35
-
-
0036850312
-
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane
-
Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., Green D.R., Newmeyer D.D. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 2002, 111:331-342.
-
(2002)
Cell
, vol.111
, pp. 331-342
-
-
Kuwana, T.1
Mackey, M.R.2
Perkins, G.3
Ellisman, M.H.4
Latterich, M.5
Schneiter, R.6
Green, D.R.7
Newmeyer, D.D.8
-
36
-
-
0032576692
-
Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c
-
Rosse T., Olivier R., Monney L., Rager M., Conus S., Fellay I., Jansen B., Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 1998, 391:496-499.
-
(1998)
Nature
, vol.391
, pp. 496-499
-
-
Rosse, T.1
Olivier, R.2
Monney, L.3
Rager, M.4
Conus, S.5
Fellay, I.6
Jansen, B.7
Borner, C.8
|